Date: 2016-02-02
Type of information: Initiation of development program
phase:
Announcement:
Company: NewLink Genetics (USA - IO)
Product:
Action mechanism:
Disease: Zika virus infection
Therapeutic area: Infectious diseases
Country:
Trial details:
Latest
news: * On February 2, 2016, NewLink Genetics announced the company initiated a project to develop new treatment options for the Zika virus. NewLink Genetics\' Infectious Disease Division, which is based in Devens, Mass., is focused on finding innovative and life-saving treatments for people who have no or few options available to them. With this goal, the team has evaluated various approaches for the prevention of infection with the Zika virus.
